Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...

Kuick Research Report Highlights Ongoing Developments In Molecular Switches Application Therapeutic Targets & Drug Delivery ...

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class ...

We expect modern medicine to be able to make sense of our health difficulties. What then, when it fails to do so for people ...

Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases -WAYNE, Pa., Feb. 12, 2025 ...

Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune ...

Aclaris Therapeutics (ACRS) announced the availability of a new publication describing properties of Aclaris Therapeutics’ ATI-2138, a novel ...

ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...

AnaptysBio (ANAB) stock climbs as its antibody therapy rosnilimab meets key goals in mid-stage rheumatoid arthritis trial, ...

A recent study reveals that age plays a significant role in the outcomes of intermittent fasting. Researchers discovered that chronic intermittent fasting disrupted the development of ...

Researchers at the (Belgium) have uncovered a previously unknown mechanism that regulates the immune response against parasites.

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.